AlphaYouMM
Congress trade
Sen. Markwayne Mullin (R-OK) sold $15K-$50K of Abbott Laboratories (ABT) stock
Markwayne Mullin, U.S. Senator (R-OK), disclosed a sale of Abbott Laboratories (ABT) stock worth $15K-$50K in a STOCK Act filing on Dec 31, 2024.
The trade happened on Dec 11, 2024, 20 days before it was made public.
ABT has moved -14.6% since the trade date, from $114.14 to $97.50 (Oct 2, 2026 close).
- Traded
- Dec 11, 2024
- Disclosed
- Dec 31, 2024
- Filing delay
- 20 days
- Price since
- -14.6%
- Source
- STOCK Act disclosure
Other trades in this disclosure (23)
- BuyAMAT$15K-$50KDec 31, 2024
- SellAXON$15K-$50KDec 31, 2024
- SellAXON$15K-$50KDec 31, 2024
- SellBMI$15K-$50KDec 31, 2024
- SellCYBR$15K-$50KDec 31, 2024
- SellETN$15K-$50KDec 31, 2024
- SellFRPT$15K-$50KDec 31, 2024
- SellFRPT$15K-$50KDec 31, 2024
- SellGS$15K-$50KDec 31, 2024
- SellLRN$15K-$50KDec 31, 2024
- SellOLLI$15K-$50KDec 31, 2024
- SellOLLI$15K-$50KDec 31, 2024
- SellPEP$15K-$50KDec 31, 2024
- SellSFM$15K-$50KDec 31, 2024
- SellSFM$15K-$50KDec 31, 2024
- SellBMI$1K-$15KDec 31, 2024
- SellCYBR$1K-$15KDec 31, 2024
- SellELF$1K-$15KDec 31, 2024
- SellELF$1K-$15KDec 31, 2024
- SellETN$1K-$15KDec 31, 2024
More ABT insider and Congress trades
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.